[DOI] [PubMed] [Google Scholar] 96.Kim Y., Kim S.B., Lee H., Kim D., Bak S.S., Yoon I., Cho S., Jeong S.J., Jeon Y., Kim J., et al
However, results vary based on the patients age, diagnosis, overall health, lifestyle, and the severity of their condition
Dovato, which combines the integrase strand transfer inhibitor dolutegravir with the nucleoside reverse transcriptase inhibitor lamivudine, was approved to treat HIV-1 infection in adolescents 12 years and older, making it the first oral, two-drug, single-tablet regimen available for this patient population, according to ViiV
Tuxhorn, J
These issues can cause havoc with the absorption of nutrients and many people dont realise that they have gut issues as symptoms can appear very gradually